New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 19, 2014
07:47 EDTVTUSVentrus to meet with the FDA
The FDA holds a Type B pre-NDA Meeting where Ventrus Biosciences (VTUS) will seek guidance on its planned New Drug Application (NDA) for DOLIZEM (diltiazem hydrochloride cream) to treat anal fissures on June 19.
News For VTUS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for VTUS

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use